|
Volumn 3, Issue 4, 1997, Pages 355-366
|
Dopamine D4 receptor antagonists
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 (1,4 BENZODIOXAN 6 YL) 4 (2 INDANYLMETHYL)PIPERAZINE;
2 AMINO 4 (4 FLUOROPHENYL) 5 [1 [4 (4 FLUOROPHENYL) 4 OXOBUTYL] 3 PYRROLIDINYL]THIAZOLE;
3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE;
7 (4 FLUOROPHENOXYMETHYL) 2 (5 FLUORO 2 PYRIMIDINYL) 2,3,4,6,7,8,9,9A OCTAHYDROPYRIDO[1,2 A]PYRAZINE;
APOMORPHINE;
AZAPERONE;
CLOZAPINE;
DOPAMINE 4 RECEPTOR;
DOPAMINE 4 RECEPTOR ANTAGONIST;
DOPAMINE RECEPTOR BLOCKING AGENT;
EMONAPRIDE;
HALOPERIDOL;
N (1 BENZYL 3 PYRROLIDINYL) 5 CHLORO 4 CYCLOPROPYLCARBOXAMIDO 2 METHOXYBENZAMIDE;
N ALLYLNORMETAZOCINE;
NEUROLEPTIC AGENT;
PD 082011;
PERGOLIDE;
RECEPTOR SUBTYPE;
SONEPIPRAZOLE;
SULPIRIDE;
UNCLASSIFIED DRUG;
YM 50001;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG DEVELOPMENT;
DRUG RECEPTOR BINDING;
HUMAN;
LOCOMOTION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
RECEPTOR AFFINITY;
REVIEW;
SCHIZOPHRENIA;
STEREOTYPY;
|
EID: 0030755226
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (22)
|
References (12)
|